Talk about a pivot. When the COVID-19 pandemic hit, Pfizer CEO Albert Bourla was one year into his tenure. Bourla, born and educated in Greece, is a 27-year veteran of the company. A trained veterinarian, he rose through the ranks of its animal health unit, and subsequently held leadership positions responsible for numerous businesses, including vaccines, oncology, and consumer products, before taking the post of chief operating officer in 2018. As he formally took the reins of the company on January 1, 2019, Bourla was focused on continuing Pfizer’s transformation into a pure-play biopharmaceutical company: placing its consumer health business in a joint venture with GlaxoSmithKline in 2019, preparing to spin off the Upjohn unit in a deal with Mylan, and rebranding the more than 170-year-old company to focus on its heritage of making scientific breakthroughs that could aid humanity. A year later, Bourla and Pfizer were intently focused on
Day: February 4, 2021
Thu, Feb 04, 2021 – 9:51 AM
UPDATED Thu, Feb 04, 2021 – 10:44 AM
DBS has raised its sustainable finance target for 2024 to S$50 billion, which is well over twice of the lender’s previous S$20 billion target for the same year.
The move stems from more companies seeking to advance their corporate sustainability agenda through sustainable financing, said DBS in a media statement issued on Thursday.
“We thought our earlier target of S$20 billion for renewable and other green financing would be a stretch and were greatly heartened at the level of customer interest in moving from business-as-usual mode to adopting sustainability in their strategies,” said Tan Su Shan, DBS’s group head of institutional banking.
Ms Tan notes that many companies have doubled down on their environmental, social and governance (ESG) commitments since the Covid-19 pandemic, with a marked increase in the number of corporate interest in